URSO FORTE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Urso Forte, and what generic alternatives are available?
Urso Forte is a drug marketed by Abbvie and is included in one NDA.
The generic ingredient in URSO FORTE is ursodiol. There is one drug master file entry for this compound. Thirty suppliers are listed for this compound. Additional details are available on the ursodiol profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Urso Forte
A generic version of URSO FORTE was approved as ursodiol by EPIC PHARMA on March 14th, 2000.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for URSO FORTE?
- What are the global sales for URSO FORTE?
- What is Average Wholesale Price for URSO FORTE?
Summary for URSO FORTE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 73 |
| Patent Applications: | 5,786 |
| Drug Prices: | Drug price information for URSO FORTE |
| DailyMed Link: | URSO FORTE at DailyMed |
Pharmacology for URSO FORTE
| Drug Class | Bile Acid |
US Patents and Regulatory Information for URSO FORTE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Abbvie | URSO FORTE | ursodiol | TABLET;ORAL | 020675-002 | Jul 21, 2004 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for URSO FORTE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Abbvie | URSO FORTE | ursodiol | TABLET;ORAL | 020675-002 | Jul 21, 2004 | 4,859,660 | ⤷ Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for URSO FORTE
See the table below for patents covering URSO FORTE around the world.
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| Canada | 1318590 | COMPOSITIONS PHARMACEUTIQUES CONTENANT DE L'ACIDE URSODESOXYCHOLIQUE (PHARMACEUTICAL COMPOSITIONS CONTAINING URSODEOXYCHOLIC ACID) | ⤷ Start Trial |
| European Patent Office | 0269516 | ⤷ Start Trial | |
| France | 2607005 | COMPOSITIONS PHARMACEUTIQUES CONTENANT DE L'ACIDE URSODESOXYCHOLIQUE | ⤷ Start Trial |
| Japan | S63141929 | MEDICINAL COMPOSITION CONTAINING ULSODEOXYCHOLIC ACID | ⤷ Start Trial |
| >Country | >Patent Number | >Title | >Estimated Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2026 - 2027
NCE-1 Patent Challenge Dates 2026 - 2027
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch